Faculty of Pharmacy, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisboa, Portugal.
Faculty of Pharmacy, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisboa, Portugal; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisboa, Portugal.
Life Sci. 2023 Sep 15;329:121838. doi: 10.1016/j.lfs.2023.121838. Epub 2023 Jun 7.
There has been an increased interest of the scientific community in cannabis and its constituents for therapeutic purposes. Although it is believed that cannabinoids can be effective for a few different conditions and syndromes, there are little objective data that clearly support the use of cannabis, cannabis extracts or even cannabidiol (CBD) oil. This review aims to explore the therapeutic potential of phytocannabinoids and synthetic cannabinoids for the treatment of several diseases. A broad search covering the past five years, was performed in PubMed and ClinicalTrial.gov databases, to identify papers focusing on the use of medical phytocannabinoids in terms of tolerability, efficacy and safety. Accordingly, there are preclinical data supporting the use of phytocannabinoids and synthetic cannabinoids for the management of neurological pathologies, acute and chronical pain, cancer, psychiatric disorders and chemotherapy-induced emetic symptoms. However, regarding the clinical trials, most of the collected data do not fully support the use of cannabinoids in the treatment of such conditions. Consequently, more studies are still needed to clarify ascertain if the use of these compounds is useful in the management of different pathologies.
科学界对大麻及其成分在治疗方面的兴趣日益增加。虽然人们认为大麻素对于几种不同的病症和综合征可能有效,但几乎没有客观数据明确支持使用大麻、大麻提取物甚至大麻二酚 (CBD) 油。本综述旨在探讨植物大麻素和合成大麻素在治疗几种疾病方面的治疗潜力。在 PubMed 和 ClinicalTrials.gov 数据库中进行了广泛的五年期搜索,以确定侧重于使用药用植物大麻素的耐受性、疗效和安全性的论文。因此,有临床前数据支持使用植物大麻素和合成大麻素来治疗神经病理学、急性和慢性疼痛、癌症、精神疾病和化疗引起的呕吐症状。然而,就临床试验而言,收集到的大多数数据并不完全支持在治疗此类疾病中使用大麻素。因此,仍需要更多的研究来澄清是否使用这些化合物对管理不同疾病有用。